MedPath

Preventive use of ascorbic acid for postoperative atrial fibrillatio

Phase 2
Conditions
cardiac arrhythmia.
Other postprocedural disorders of circulatory system, not elsewhere classified
Registration Number
IRCT2016090228945N2
Lead Sponsor
Vice chancellor for research, Islamic Azad University, Najafabad branch
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
330
Inclusion Criteria

inclusion:
no arrhythmia, coronary artery bypass alone, normal sinus rhythm preoperatively

exclusion criteria:
emergency operation, antiarryhthmic drug postoperatively

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Atrial fibrillation. Timepoint: 3 days in ICU then in ward. Method of measurement: ECG.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath